Fig. 1
From: Targeting deubiquitinating enzymes in cancer stem cells
CSCs cause cancer relapse and resistance after conventional cancer therapy. The conventional therapy targeting the tumor bulk without targeting the CSCs leads to tumor recurrence
Advertisement
Fig. 1 | Cancer Cell International
